Compare NNVC & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNVC | ATCH |
|---|---|---|
| Founded | 2005 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 29.6M |
| IPO Year | 2008 | 2024 |
| Metric | NNVC | ATCH |
|---|---|---|
| Price | $1.34 | $0.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 482.1K | ★ 1.5M |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.00 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $84.47 |
| Revenue Next Year | N/A | $39.32 |
| P/E Ratio | ★ N/A | $3.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $0.14 |
| 52 Week High | $2.23 | $1.92 |
| Indicator | NNVC | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 45.82 | 39.76 |
| Support Level | $1.13 | $0.19 |
| Resistance Level | $1.48 | $0.21 |
| Average True Range (ATR) | 0.11 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 40.74 | 18.22 |
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.